March 10 news, Lenovo Group Chairman and CEO, China University of Science and Technology (hereinafter referred to as China University of Science and Technology) alumni Yang Yuanqing in his personal name to the alma mater donated 10 million yuan, to protect the China University of Science and Technology new crown epidemic research, and promote the China University of Science and Technology Institute of Public Health, public health and preventive medicine discipline series.
Inflammatory storms are an important factor in the development of severe and critical illness in patients with new coronary pneumonia. Professor Wei Haiming of the Department of Life Sciences and Medicine of The Chinese University of Science and Technology combined with the basic research results of the team immunology field of Xu Xiaoling, director of the first hospital affiliated with The Chinese University of Science and Technology, and successfully adopted “tozhu mono-resistance” as an inhibitor on the basis of the initial understanding of the mechanism. At present, in the General Office of the National Health and Health Commission, the Office of the State Administration of Traditional Chinese Medicine issued the “New Coronary Virus Pneumonia Diagnosis and Treatment Program (Trial Seventh Edition)”, China University of Science and Technology “Tozhu mono-anti-conventional treatment” to suppress the “inflammatory storm” treatment plan into the compilation, as an important program to treat seriously ill patients, reduce the rate of death and death throughout the country.
“In just over a month, the alma mater has made encouraging achievements in basic scientific research, clinical research and clinical treatment collaboration, providing strong scientific and technological support for the prevention and control of first-line outbreaks,” Yang said. I hope this donation will create better scientific research conditions for the scientific researchers who are fighting in the front line, accelerate the scientific and technological research, and help win the fight against the epidemic. “
In addition, China University of Science and Technology to the epidemic research as a starting point, and actively plan the construction of the University of Science and Technology public health disciplines. The Institute of Public Health focuses on biomedical big data, group health science, evidence-based medicine, molecular and genetic epidemiology, health promotion science application and transformation research, the development goal is to become a first-class, internationally renowned public health research institutions in China.
Bao Xin, president of the Chinese University of Science and Technology, and academicians thanked Yang Yuanqing alumni for their donations, saying: “Yang Yuanqing alumni have always been very concerned about the development of their alma mater’s various undertakings. In 2017, he donated 10 million yuan to set up the Yang Yuanqing Education Fund to encourage outstanding undergraduate and graduate students who love science, and to support professors with outstanding scientific achievements. “
Recently, Lenovo Group announced that it is working with Intel and Huada Gene to accelerate genomic characteristics analysis of the new COVID-19 coronavirus. This research is critical to creating better diagnostic methods, designing effective vaccines, or other protective measures, such as immunotherapy, in the future.
Lenovo and Intel’s technology for Huada Gene includes a large, high-performance computing cluster that can be used to process high-throughput data read from Huada DNBSEQ-T7 sequencing systems. Huada Gene researchers will be able to further accelerate their study of the genomic characteristics of new coronaviruses through new high-performance computing and genomic analysis technologies, as well as the resources and expertise associated with Intel and Lenovo. The technology will enable scientists to study the virus’s toxicity, transmission patterns, and interactions between pathogens and hosts, which in turn will help epidemiological and vaccine design research.